1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of epidemic H1N1 infection
5.1.1.2. Demand for inactivated influenza vaccine in pregnant women and children
5.1.1.3. Shift towards cell-based manufacturing
5.1.2. Restraints
5.1.2.1. Time consuming manufacturing process and high cost
5.1.3. Opportunities
5.1.3.1. Public -private partnerships for cost effective supply
5.1.3.2. Technological advancements in the vaccines
5.1.4. Challenges
5.1.4.1. Common side effects associated with H1N1 vaccines
5.2. Cumulative Impact of COVID-19

6. H1N1 Vaccines Market, by Route of Administration
6.1. Introduction
6.2. Intradermal Vaccines
6.3. Intramuscular Vaccines
6.4. Intranasal Vaccines

7. H1N1 Vaccines Market, by Vaccine Type
7.1. Introduction
7.2. Intraderma
7.3. Intramuscular
7.4. Intranasal

8. H1N1 Vaccines Market, by Type of Brand
8.1. Introduction
8.2. Agripal
8.3. Fiuarix
8.4. Influgen
8.5. Influvac
8.6. Nasovac
8.7. Others
8.8. Vaxigrip

9. H1N1 Vaccines Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy

10. Americas H1N1 Vaccines Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific H1N1 Vaccines Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa H1N1 Vaccines Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abbott
14.2. Baxter International
14.3. Cipla
14.4. GSK
14.5. Hualan Biological Engineering
14.6. Merck
14.7. Mitsubishi Tanabe Pharma
14.8. Pfizer
14.9. Sanofi
14.10. Sinovac Biotech

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL H1N1 VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL H1N1 VACCINES MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2027 (%)
FIGURE 4. GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 6. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRADERMAL VACCINES, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRADERMAL VACCINES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR VACCINES, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR VACCINES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRANASAL VACCINES, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRANASAL VACCINES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL H1N1 VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 VS 2027 (%)
FIGURE 13. GLOBAL H1N1 VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL H1N1 VACCINES MARKET SIZE, BY VACCINE TYPE, 2027
FIGURE 15. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRADERMA, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRADERMA, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRANASAL, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRANASAL, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2020 VS 2027 (%)
FIGURE 22. GLOBAL H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2020 VS 2027 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2027
FIGURE 24. GLOBAL H1N1 VACCINES MARKET SIZE, BY AGRIPAL, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL H1N1 VACCINES MARKET SIZE, BY AGRIPAL, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL H1N1 VACCINES MARKET SIZE, BY FIUARIX, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL H1N1 VACCINES MARKET SIZE, BY FIUARIX, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL H1N1 VACCINES MARKET SIZE, BY INFLUGEN, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL H1N1 VACCINES MARKET SIZE, BY INFLUGEN, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL H1N1 VACCINES MARKET SIZE, BY INFLUVAC, 2018-2027 (USD MILLION)
FIGURE 31. GLOBAL H1N1 VACCINES MARKET SIZE, BY INFLUVAC, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL H1N1 VACCINES MARKET SIZE, BY NASOVAC, 2018-2027 (USD MILLION)
FIGURE 33. GLOBAL H1N1 VACCINES MARKET SIZE, BY NASOVAC, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL H1N1 VACCINES MARKET SIZE, BY OTHERS, 2018-2027 (USD MILLION)
FIGURE 35. GLOBAL H1N1 VACCINES MARKET SIZE, BY OTHERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL H1N1 VACCINES MARKET SIZE, BY VAXIGRIP, 2018-2027 (USD MILLION)
FIGURE 37. GLOBAL H1N1 VACCINES MARKET SIZE, BY VAXIGRIP, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2027 (%)
FIGURE 39. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2027 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 41. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 42. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 43. GLOBAL H1N1 VACCINES MARKET SIZE, BY ONLINE PHARMACY, 2018-2027 (USD MILLION)
FIGURE 44. GLOBAL H1N1 VACCINES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 45. GLOBAL H1N1 VACCINES MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 46. GLOBAL H1N1 VACCINES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 47. AMERICAS H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. ARGENTINA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. BRAZIL H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. CANADA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. MEXICO H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. UNITED STATES H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. AUSTRALIA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. CHINA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. INDIA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. INDONESIA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. JAPAN H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. MALAYSIA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. PHILIPPINES H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. SINGAPORE H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. SOUTH KOREA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. TAIWAN H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. THAILAND H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. FRANCE H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. GERMANY H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. ITALY H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. NETHERLANDS H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. QATAR H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. RUSSIA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. SPAIN H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. GLOBAL H1N1 VACCINES MARKET: FPNV POSITIONING MATRIX
FIGURE 78. GLOBAL H1N1 VACCINES MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 79. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL H1N1 VACCINES MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL H1N1 VACCINES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRADERMAL VACCINES, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR VACCINES, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRANASAL VACCINES, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL H1N1 VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRADERMA, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL H1N1 VACCINES MARKET SIZE, BY AGRIPAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL H1N1 VACCINES MARKET SIZE, BY FIUARIX, BY REGION, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL H1N1 VACCINES MARKET SIZE, BY INFLUGEN, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL H1N1 VACCINES MARKET SIZE, BY INFLUVAC, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL H1N1 VACCINES MARKET SIZE, BY NASOVAC, BY REGION, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL H1N1 VACCINES MARKET SIZE, BY OTHERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL H1N1 VACCINES MARKET SIZE, BY VAXIGRIP, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL H1N1 VACCINES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL H1N1 VACCINES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. AMERICAS H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. ARGENTINA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. BRAZIL H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. CANADA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. MEXICO H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. UNITED STATES H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. AUSTRALIA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. CHINA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. INDIA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. INDONESIA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. JAPAN H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. MALAYSIA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. PHILIPPINES H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. SINGAPORE H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. SOUTH KOREA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. TAIWAN H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. THAILAND H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. FRANCE H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. GERMANY H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. ITALY H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. NETHERLANDS H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 46. QATAR H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. RUSSIA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 48. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 49. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 50. SPAIN H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 51. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 52. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 53. GLOBAL H1N1 VACCINES MARKET: SCORES
TABLE 54. GLOBAL H1N1 VACCINES MARKET: BUSINESS STRATEGY
TABLE 55. GLOBAL H1N1 VACCINES MARKET: PRODUCT SATISFACTION
TABLE 56. GLOBAL H1N1 VACCINES MARKET: RANKING
TABLE 57. GLOBAL H1N1 VACCINES MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 58. GLOBAL H1N1 VACCINES MARKET: MERGER & ACQUISITION
TABLE 59. GLOBAL H1N1 VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 60. GLOBAL H1N1 VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 61. GLOBAL H1N1 VACCINES MARKET: INVESTMENT & FUNDING
TABLE 62. GLOBAL H1N1 VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 63. GLOBAL H1N1 VACCINES MARKET: LICENSE & PRICING

Companies Mentioned

Abbott
Baxter International
Cipla
GSK
Hualan Biological Engineering
Merck
Mitsubishi Tanabe Pharma
Pfizer
Sanofi
Sinovac Biotech